Patent Dispute over Axiron

[Jinzang]

Pan Pharmaceutical has filed a request with the FDA to market a generic version of Axiron transdermal testosterone. Eli Lily is suing to block the request, claiming it violates seven of its patents.

news article

 

[Nelson Vergel]

Pharma plays games to block generic testosterone gels. They have been successful so far in paying off generic companies so that they withdraw their applications.


Abbott files US lawsuit against Teva over generic version of AndroGel

AbbVie sued by FTC for paying to delay generic drug